| mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.9 |
| mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |